chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Joint pain and fatigue started the evening I received the vaccine. Fever and headache woke me up out of my sleep around 3:30am that night/next morning. All symptoms continued throughout the day after receiving vaccine. Two days after receiving vaccine, my menstrual cycle started earlier than it should have, cramps were more intense than usual, bleeding was much heavier than usual, and clotting in cycle was noticed, which is also abnormal for my cycles.
enlarge lymph node under left armpit detected in sonogram. Not visual to eye or felt with manual examination; This is a spontaneous report from a contactable consumer reported for herself. A 66-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, LOT# EL9262), via an unspecified route of administration in left arm on 03Feb2021 at second single dose for covid-19 immunisation. Medical history included high blood pressure, hypothyroidism, low vitamin D, breast cancer survivor since Jan2018. No allergies to medications, food, or other products. Patient was not pregnant at the time of vaccination. The patient previously took bnt162b2 (LOT# EL1284) in left arm on 13Jan2021 at first single dose for covid-19 immunisation. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was receiving yearly mammogram and sonogram for breast cancer survivor since Jan2018. Enlarge lymph node under left armpit was detected in sonogram. Not visual to eye or felt with manual examination. Event was considered as non-serious. It was unknown whether treatment was received. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the event was unknown.
This spontaneous report as received from certified medical assistant refers to an unspecified number of patients of unknown age and unknown gender. Pertinent medical history, drug reactions or allergies were not reported. On an unknown dates the unspecified number of patient were vaccinated with improperly stored doses of RECOMBIVAX HB (dose, dose number, route, anatomical location, lot number and expiration date were unspecified). No adverse effects reported. No concomitant therapies were reported. The outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received an vaccine that expired on 9/15/2022 (1 day after date of expiration) from incorrect stock - should have been state supplied vaccine.
Patient wanted to get Pfizer vaccine. He was given Moderna vaccine. Patient does not report any adverse events following the first dose of Moderna.
4 cases where people turn up positive COVID tests after the booster; 4 cases where people turn up positive COVID tests after the booster; This is a spontaneous report received from a contactable reporter (Physician) from medical information team.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in 2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for COVID-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE and COVID-19, all medically significant with onset 2022, outcome "unknown" and all described as "4 cases where people turn up positive COVID tests after the booster". The reporting physician mentioned that he knew of 4 cases where people turn up positive COVID tests after the booster: himself; two patients; then another one who received it last Thursday and then had COVID like symptoms throughout the week. He was waiting for her to call him about the results. He also spoke to a patient this morning, a friend who also got a bivalent the day after. He did some research and found an article news where someone also got the booster on 04Oct2022 and got very sick and tested positive for COVID test in the past week. It seemed unusual the frequency of people reporting COVID. This case was considered as non-serious by the reporter. The patient underwent the following laboratory tests and procedures: COVID tests: (2022) Positive.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: A contributory role of BNT162B2 to event 4 cases where people turn up positive COVID tests after the booster cannot be excluded based on temporal association and available information.,Linked Report(s) : US-PFIZER INC-202201296261 same reporter/drug/event, different patients;
Had red area near site of injection. It had a hard knot. I iced it all day on 10/17. On 10/18 my doctor told me to go to ER.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Sep2022 at 16:00 as dose 5 (booster), single (Lot number: GH9694) at the age of 49 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing); "colon removed" (unspecified if ongoing), notes: I have had most of my colon removed; "Bee Venom" (unspecified if ongoing), notes: Known allergies: Bee venom. The patient's concomitant medications were not reported. Past drug history included: Macrodantin (nitrofurantoin);, reaction(s): "Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: Anti-viral details: product=COVID 19 Treatment, brand=Pfizer, Treatment start date: 02Jan2023, Treatment stop date: 03Jan2023, Lot number: GF4000, Indication: Treatment of COVID-19. Did you/the patient previously receive a COVID-19 Vaccine: Yes. At 5:15 pm on Monday, 02Jan2023, I took the first dose (3 pills) of Paxlovid.
Approximately 1 hour after vaccinations received daughter felt weak, lethargic, had low grade fever of 100, pain on lower back and tingling in legs. MD was contacted. MD advised to continue to monitor and if fever increased and/or pain worsened to call MD back. Fever resolved after Tylenol given. Pain in lower back and legs did not worsen but stayed constant. Daughter lethargic for approx 24 hours. MD followed up with call later that evening. Continued to monitor. Daughter felt better after 24 hours. Back pain subsided for a few days but continued to come and go. Since vaccinations my daughter has had constant lower back pain. Several follow ups with her primary MD were made. Several tests done such as CT, MRI, labs. Referral to specialist were made to rule out any other issues. Referrals to neurology, rheumatology, orthopedics, Physical therapy, spine specialist, pain specialist, acupuncture, stress relieving measures taken..to name a few. All steps were taken to rule out any other issues. At first MDs did not believe back pain could be related to immunizations. It wasn't until we had follow up appointments with specialists that it was now being discussed as the vaccinations being the cause of my daughters constant and on-going back pain. This pain has caused her to miss weeks of school, cause her stress and miss out on activities.
body ache, headache, fever, coughing, trouble walking, difficulty breathing, blood pressure fluctuating, weak, difficulty keeping food down dehydrated, covid 19
This medically confirmed health authority report (initial receipt 22-FEB-2016) concerns a patient (gender unknown). On 30-SEP-2015, the nurse had re-used the syringe for multiple patients at a employee influenza vaccination clinic. The nurse brought three multiple dose vials of the vaccine that were intended for another event and were stored in her personal fridge without temperature monitoring. The nurse reported using two syringes she found in her supplies to administer vaccine to 67 patients. She reported wiping the syringes with alcohol and using a new needle for each patient. Only 2 multiple dose vials of vaccine (10 doses/vial) were used for 67 adult patients. The patient (one of the 67 patients) was administered intramuscular AFLURIA injection , batch number:11049221A) in the arm. The patient was offered blood pathogen testing (hep B, hep C, HIV), hepatitis B vaccine and flu vaccine. However, the test results were not received as the patient was not seen at the sponsored clinic and had the results-tested through a private physician. The outcome was unknown. Reporter's comments: The health authority assessed the events as non-serious.
First dose Pfizer COVID vaccine given 1/6/21 and second dose given at 16 days 1/22/21.
MENACTRA Lot# U3433AA - Exp. 08/02/11 vaccine administered 08/10/11, 8 days after expiration date. MENACTRA LOT# U3778AA Exp. 10/14/12 readministered: 8/15/11.
Patient is pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 04-Jun-2021. On 29-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant). On 29-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant) had resolved.            No Concomitant medications provided. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Feb-2021: Upon internal review on 21-Jul-2021, patient, events, analysis and regulatory reports tabs were updated.
I went to sleep around 2:30 AM on May 17 feeling a little achey and woke up around 4:00 AM on May 17 feeling very strange. The only way to describe it was it felt like electricity was radiating throughout my body and like I was being zapped with pulses in my head, ears and body. Then I went on to be freezing cold, with uncontrollable shaking and possibly a high fever (as my shirt was burning hot), with body aches. I started feeling better that night at midnight on May 18 (approximately 19-20 hours after onset). The symptoms of feeling electricity in my body stopped after the first 1-2 hours though.  Overall, I felt very very sick in those 20 hours. I did not seek treatment as adverse affects was expected.
Caused his lupus to reactivate; Caused his lupus to reactivate; Inflammation around the joints; Lower back pain; Severe hip pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 26Sep2023 at 12:30 as dose 1, single (Lot number: 1389554) at the age of 30 years, in right arm for COVID-19 immunisation. The patient's relevant medical history included: "hips replaced" (unspecified if ongoing), notes: 1 year prior to vaccine; "Lupus" (unspecified if ongoing). Concomitant medication(s) included: LOVENOX [LEVOFLOXACIN]. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The following information was reported: BACK PAIN (non-serious) with onset 27Sep2023 at 05:00, outcome "recovering", described as "Lower back pain"; ARTHRALGIA (non-serious) with onset 27Sep2023 at 05:00, outcome "recovering", described as "Severe hip pain"; SYSTEMIC LUPUS ERYTHEMATOSUS (medically significant), DISEASE RECURRENCE (medically significant), outcome "unknown" and all described as "Caused his lupus to reactivate"; ARTHRITIS (non-serious), outcome "unknown", described as "Inflammation around the joints". The events "caused his lupus to reactivate", "lower back pain", "severe hip pain" and "inflammation around the joints" required physician office visit. Therapeutic measures were not taken as a result of back pain, arthralgia. Additional information: The patient began to have hip and lower back pain on 27Sep2023 at 05:00. He woke up on 28Sep2023 to severe hip pain. He had both hips replaced 1 year prior to vaccine. He spoke to the doctor and the vaccine possibly caused inflammation around the joints or caused his lupus to reactivate.
Patient phoned and reported continued headache since vaccination, SOB, and continuous watering of unilateral eye.
Information has been received from a licensed practical nurse concerning a patient was vaccinated with a dose of Rotateq. The LPN reported that the patient choked and spit some of the vaccine out causing some of the vaccine to go into the medical assistant's eyes. It was unknown if medical attention was sought and no other symptoms were noted.
Nausea and vomiting, headache, muscle ache, painful red rash on left upper arm.
Information has been received from a nurse concerning a 14 year old female who on 02-JUL-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot no 657449/0597U). On 05-JUL-2007 the patient called the office and reported that on 02-JUL-2007 she had a 4 inch diameter redness of injection site in the L arm. On 06-JUL-2007 the patient called again because of continued symptoms. This is one of several reports received from the same source. No further information is available.
bruise about injection site and red spot underneath; bruise about injection site and red spot underneath; bruise right about injection site which she is not comfortable about; she got the booster; it is about 5 inches by 1 inch and is just getting bigger, wants to know if this is norma/bruise that is slightly above the injection site and a red spot that is getting worse; itchy/itches below the injection site that is painful; itchy/itches below the injection site that is painful; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 19Nov2021 (Lot number: 33030BD) as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Second dose, LOT-ER8731), administration date: 22Apr2021, for Covid-19 immunization, reaction(s): "tired", "sore arm"; Bnt162b2 (First dose, LOT-ER8735), administration date: 01Apr2021, for Covid-19 immunization. The following information was reported: VACCINATION SITE BRUISING (non-serious), VACCINATION SITE ERYTHEMA (non-serious) all with onset 20Nov2021, outcome "not recovered" and all described as "bruise about injection site and red spot underneath"; VACCINATION SITE PAIN (non-serious) with onset Nov2021, outcome "unknown", described as "itchy/itches below the injection site that is painful"; VACCINATION SITE PRURITUS (non-serious) with onset Nov2021, outcome "unknown", described as "itchy/itches below the injection site that is painful "; VACCINATION SITE DISCOMFORT (non-serious) with onset 20Nov2021, outcome "not recovered", described as "bruise right about injection site which she is not comfortable about"; CONDITION AGGRAVATED (non-serious) with onset Nov2021, outcome "not recovered", described as "it is about 5 inches by 1 inch and is just getting bigger, wants to know if this is norma/bruise that is slightly above the injection site and a red spot that is getting worse"; IMMUNISATION (non-serious) with onset 19Nov2021, outcome "unknown", described as "she got the booster".  Follow-up attempts are completed. No further information is expected.
widespread urticarial plaques / hives with associated itching and burning.  No associated wheezing /respiratory issues
pt recv vax & 1wk p/vax pt devel a rash consisting of red bumps on arm & back the size of dimes;
C/o 12 hours after receiving vaccine, states lymph nodes under (L) arm were very painful and swollen for 3 days.
Flu; Initial information regarding this unsolicited valid non-serious social media case received from a consumer (patient) on 09-Nov-2020.  This case involves a patient with unknown demographics who experienced flu, when received vaccine INFLUENZA VACCINE (dang shot).  Relevant medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient experienced flu, unknown latency following the administration of INFLUENZA VACCINE.  Relevant laboratory test was not reported.  It was not reported if the patient received a corrective medication.  At the time of reporting, the outcome was unknown for the reported events.  There will be no information available on batch number for this case.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was vaccinated with ZOSTAVAX (Lot#, dose number, dose/frequency, route and duration were unspecified) on 09-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. It was reported that the patient inadvertently received ZOSTAVAX instead of VARIVAX on 09-AUG-2012. No symptoms reported. It was unspecified whether the patient had sought medical attention. No treatment information was reported. At the time of reporting the outcome was unknown. Additional information has been requested.
Patient got first dose of Pfizer. Was asked to wait 15 minutes and he did. Came up and asked if he can leave after 15 minutes confirmed he felt okay and said it was ok. He came back rushing a couple minutes later saying he wasn?t feeling good. He was leaning on the counter heavy breathing. He looked like he was going to faint so walked him to a chair. When asking more questions patient didn?t respond to any questions being asked. He did have a pulse and was breathing though. He asked for water. When he looked like he was going to faint the ambulance was called. And paramedics took him
Wrong vaccine and it was not Covid vaccine; Running low Temperature; Slight nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (Wrong vaccine and it was not Covid vaccine), BODY TEMPERATURE DECREASED (Running low Temperature), NAUSEA (Slight nausea) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ?26B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced WRONG PRODUCT ADMINISTERED (Wrong vaccine and it was not Covid vaccine), BODY TEMPERATURE DECREASED (Running low Temperature), NAUSEA (Slight nausea) and HEADACHE (Headache). On 14-Apr-2021, WRONG PRODUCT ADMINISTERED (Wrong vaccine and it was not Covid vaccine) had resolved. At the time of the report, BODY TEMPERATURE DECREASED (Running low Temperature), NAUSEA (Slight nausea) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: low (Low) Running slightly low body temperature.         Patient said that the batch number of the administered vaccine is not at all exist(26B21A) Concomitant product information was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow up was received on 15 APR 2021.Added new event Headache
Began feeling short of breath and dizzy. Was given 25mg Benadryl PO and symptoms resolved
Patient got covid after boosters.; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Patient got covid after boosters.) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Patient got covid after boosters.). At the time of the report, COVID-19 (Patient got covid after boosters.) outcome was unknown. Not Provided    Patient received the Moderna COVID-19 vaccines in primary series.  No concomitant medications were reported.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-690376 (E2B Linked Report). This case was linked to MOD-2022-690377 (Patient Link).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-690376:MOD-2022-690376 - Reporter's Case
Pt vaccinated with Engerix-B developed diarrhea, bad headache, events occurred the day after vaccinee received a first dose. Missed one day of work. Reporter indicated "pt seems okay right now."
No known adverse reaction. Tdap given instead of DTaP. CDC Hot Line was called to get information about how to follow-up. Advised to file VAERS report and discount Tdap and give DTaP as soon as feasible. Dr. was notified and recommended scheduling patient for DTaP in one month.
Patient injected with Moderna vaccine at approximately 1100 on 09/15/21. Approximately 15 minutes after injection the patient began to complain of numbness in the right arm from deltoid to antecubital region. No redness, swelling loss of motion. Fingers were warm and had full ROM. No distress noted. No breathing difficulties noted. Patient reported feeling moderately anxious. Approximately 30 minutes after injection the patient began complaining of a burning sensation in the right arm from deltoid to antecubital region. Patient was encouraged to go to his own provider or to go to the emergency room. Patient called his wife to pick him up. at approximately 1200 the patient left the facility for the emergency room.